Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?

Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?

Multiple Myeloma (MM) is an incurable malignant plasma cell disorder. We have evaluated the counts of Multiple Myeloma Cells (MMCs) and normal plasma cells (N-PCs), seven days after high-dose melphalan (HDM) and autologous stem transplantation (ASCT). Two third of patients had detectable minimal res...

Full description

Bibliographic Details
Main Authors: Caraux, Anouk, Vincent, Laure, Bouhya, Salahedine, Quittet, Philippe, Moreaux, Jérôme, Requirand, Guilhem, Veyrune, Jean-Luc, Olivier, Gaëlle, Cartron, Guillaume, Rossi, Jean-François, Klein, Bernard
Format: Online
Language:English
Published: Impact Journals LLC 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539173/

Similar Items

Similar Items